Nordisk Sp ADR-B (NVO)

Healthcare stocks rose broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 0.1%. NASDAQ:CLDX, NASDAQ:ISIS, NASDAQ:MNKD, NASDAQ:THRX, NASDAQ:INCY, NASDAQ:SGEN, NASDAQ:CLVS, NASDAQ:ARNA, NASDAQ:MYGN, NASDAQ:REGN, NYSE:RDY, NYSE:LCI, NASDAQ:HMSY, NYSE:GSK, NYSE:NVO, NYSE:WST, NASDAQ:ALGN, NYSE:GB, NASDAQ:NEOG

Biggest Movers in Healthcare Stocks Now – ISRG NKTR PCRX QCOR

By Portfolio Grader Apr 1, 2014

Healthcare stocks advanced 0.8% on Wall Street on Tuesday morning. NASDAQ:ISRG, NASDAQ:NKTR, NASDAQ:PCRX, NASDAQ:QCOR, NASDAQ:AUXL, NASDAQ:ALXN, NASDAQ:CELG, NASDAQ:HZNP, NASDAQ:THRX, NASDAQ:REGN, NASDAQ:MDCO, NYSE:TEVA, NYSE:SNY, NYSE:NVO, NYSE:COV, NYSE:GSK, NYSE:NVS, NASDAQ:ENDP, NASDAQ:SGMO, NASDAQ:NVDQ

Biggest Movers in Healthcare Stocks Now – BAX ICLR NVO AMGN

By Portfolio Grader Mar 27, 2014

Healthcare stocks declined broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.4%. NYSE:BAX, NASDAQ:ICLR, NYSE:NVO, NASDAQ:AMGN, NYSE:CHE, NASDAQ:NPSP, NASDAQ:SHPG, NYSE:COV, NASDAQ:MDCO, NYSE:RMD, NASDAQ:HALO, NASDAQ:ISIS, NASDAQ:IRWD, NASDAQ:SGMO, NASDAQ:CLVS, NASDAQ:ENDP, NYSE:LCI, NASDAQ:ACAD, NYSE:VRX, NASDAQ:HZNP

70 Trades To Make Now That Rates May Rise

By Louis Navellier, Editor, Growth Investor Mar 25, 2014

It's a bit of a strange market, with investors reacting to 'news' like Yellen's comments and Crimea. Make some sense of it with these trading ideas

52 Trades to Beat the Mutual Fund Slump

By Louis Navellier, Editor, Growth Investor Feb 11, 2014

I've taken some of the guesswork out of stock picking for you by updating my ratings for these 52 stocks.

3 Huge Healthcare Trends Can Fatten Your Portfolio

By Traders Reserve Nov 8, 2013

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities

3 Ways to Trade Diabetes Treatment

By Will Ashworth, InvestorPlace Contributor Jun 26, 2013

The treatment of diabetes continues to be a huge boon to drug companies. Here is a look att three potential stock picks for the space.

Winners After Novo Nordisk’s Insulin Rejection

By James Brumley, InvestorPlace Feature Writer Feb 14, 2013

Eli Lilly and Sanofi look like the biggest players that are best suited to benefit from Novo Nordisk's diabetes-drug setback, but a smaller player could emerge, too.

Little News, Little Wiggle — Monday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor Feb 11, 2013

A slow Monday featured a lack of economic or earnings news and led investors to mostly sit on the sidelines for the day.

3 Healthcare Stocks Ready for a Breather

By Will Ashworth, InvestorPlace Contributor Feb 6, 2013

It's the hottest sector in the S&P 500 so far this year, and that means some big-name pullbacks are likely. Here are three likely candidates.

Laying Out Our Strategy for the Second Half of 2012

By Hilary Kramer, Editor, GameChangers Jul 5, 2012

The rest of the year will be driven in large part by four factors. See what they are -- and which five stocks are in a strong position to do well.

Earnings Season Brings Joy or Sorrow

By Louis Navellier, Editor, Growth Investor Apr 18, 2012

Earnings season is difficult for everyone, as winners tend to get big stock bumps, while losers tend to go the other way: down. Hang on!

Here Comes a Bidding War for Amylin

By Gene Marcial, InvestorPlace Contributor Apr 2, 2012

Approval of its diabetes drug has Big Pharma banging on its door, with Bristol-Myers Squibb already said to have offered $3.5 billion, or $22 per share.